(Q46642513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Siamak Daneshmand

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Anirban P Mitra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

7

Inderbir S Gill

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Tanya B Dorff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Eila C Skinner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Anne K Schuckman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Gus Miranda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

4 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

846-854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

Late Oncological Occurrences Following Radical Cystectomy in Patients with Bladder Cancer

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Upper tract transitional cell carcinoma following cystectomy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Surgical factors influence bladder cancer outcomes: a cooperative group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10455.X

10.1111/J.1464-410X.2011.10455.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21812902%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference